Clinical Trials Unit
The ADAPT Sepsis Trial has shown a new biomarker testing protocol for Sepsis could safely stop antibiotic treatment earlier than current care.
The trial was commissioned and funded by the National Institute for Health and Care research (NIHR), and the leading partners were University of Manchester, Northern Care Alliance and Warwick Medical’s School’s Clinical Trials Unit .
The results were presented to a global audience at the prestigious Critical Care Reviews meeting Down Under on 10th December 2024 and recently published in JAMA. The paper can be found here: https://jamanetwork.com/journals/jama/fullarticle/2828036 [jamanetwork.com]
Research excellence
The Warwick Clinical Trials Unit (WCTU) has a strong track record in delivering excellent research. Established in 2005, we received full registration status from the UKCRC in 2007.
We care about patient centred outcomes and we want to find ways to improve them. Our trials and investigations help us to do that. We're not afraid to ask the difficult questions, by leading and supporting clinical trials that seek to find answers. We have a reputation for challenging long-established norms.
Discover Our Work
Our core portfolio trials cover:
- Cancer
- Emergency and critical care
- Methodology
- Maternal Health
- Surgery/Pain and Rehabilitation
Learn more about current, recruiting and follow up trials as well as completed trials in our Trials Portfolio section.
Collaborate with us
We specialise in the development and delivery of large multicentre clinical trials.
Whether you need support for specific services or full trial management, we can help.
Discover more about the services we provide by visiting Collaborate with WCTU.
Our funding
Warwick CTU is part of the NIHR Research Support Service – RSS – a national service providing support and advice to researchers based in England developing funding applications at all stages of the research pathway, from pre award to post award and delivery.
